SEC Filings

Filing date Description Form Filing Group View

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D
Other
View HTML

An amendment to a 3 filing. Non-EDGAR filing

3/A
3,4,5
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

An amendment to the SC 13G filing

SC 13G/A
Other
View HTML

An amendment to the SC 13G filing

SC 13G/A
Other
View HTML

An amendment to the SC 13G filing

SC 13G/A
Other
View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G
Other
View HTML

Data provided by Kaleidoscope.

Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.